Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 14Bayer Inc.
02 3Alcon Canada Inc.
03 1Gowling WLG (Canada) LLP
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Brand Name : AVELOX
Patent Number : 2086914
Filing Date : 1993-01-07
Strength per Unit : 400mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Brand Name : AVELOX
Patent Number : 2192418
Filing Date : 1996-12-09
Strength per Unit : 400mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Brand Name : AVELOX
Patent Number : 1340114
Filing Date : 1989-07-13
Strength per Unit : 400mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Brand Name : AVELOX I.V.
Patent Number : 2086914
Filing Date : 1993-01-07
Strength per Unit : 400mg in a pre - mixed 250ml minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Brand Name : AVELOX I.V.
Patent Number : 1340114
Filing Date : 1989-07-13
Strength per Unit : 400mg in a pre - mixed 250ml minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-11-03
Date Granted : 1998-11-03
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Brand Name : AVELOX I.V.
Patent Number : 2192418
Filing Date : 1996-12-09
Strength per Unit : 400mg in a pre - mixed 250ml minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Brand Name : IZILOX I.V.
Patent Number : 2086914
Filing Date : 1993-01-07
Strength per Unit : 400 mg / pre - mixed 250 mL minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-01-07
Date Granted : 2005-03-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2015-11-13
Date Granted : 1998-11-03
Brand Name : IZILOX I.V.
Patent Number : 1340114
Filing Date : 1989-07-13
Strength per Unit : 400 mg / pre - mixed 250 mL minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-11-13
Date Granted : 1998-11-03
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Brand Name : IZILOX I.V.
Patent Number : 2192418
Filing Date : 1996-12-09
Strength per Unit : 400 mg / pre - mixed 250 mL minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-12-09
Date Granted : 2001-06-12
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-07-25
Date Granted : 2009-02-17
Brand Name : IZILOX I.V.
Patent Number : 2378424
Filing Date : 2000-07-25
Strength per Unit : 400 mg / pre - mixed 250 mL minibag
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-07-25
Date Granted : 2009-02-17
